THERABIOLOGICS
The Company: Formed in June 2011, TheraBiologics is a clinical stage biopharmaceutical company developing a proprietary human neural stem cell (NSC) platform for targeted delivery of potent therapeutics to malignant tumors, with an initial focus on brain cancer. TheraBiologics Phase I lead program, TBX-01, is the first–in-human clinical trial of an FDA approved, genetically modified NSC line for cancer treatment. TheraBiologics is seeking $5 million in seed investment to advance our lead anti-... cancer product, hire full-time leadership, and and transition the company from the academic to commercial development setting. The Seed and possible Series A funding, together with $24 million in already secured grant funding (designated for the preclinical products in the pipeline, expected to go to clinical trial in 2015) is expected to advance TheraBiologics to the later stages of product development, and an exit for investors through acquisition or IPO.
THERABIOLOGICS
Industry:
Biotechnology Health Care Medical
Founded:
2011-06-11
Address:
Arcadia, California, United States
Country:
United States
Website Url:
http://www.therabiologics.com
Total Employee:
1+
Status:
Active
Contact:
626-590-4481
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Google Apps For Business GoDaddy DNS Vimeo
Similar Organizations
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Fischer Imaging
Fischer Imaging develops mammography systems for breast imaging.
Verismo Therapeutics
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.therabiologics.com
- Host name: 128.97.27.37
- IP address: 128.97.27.37
- Location: Los Angeles United States
- Latitude: 34.0648
- Longitude: -118.4414
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90024
More informations about "TheraBiologics"
TheraBiologics, Inc.: Contact Details and Business Profile
The NAICS codes for TheraBiologics, Inc are [54, 541714, 541, 54171, 5417]. What is the SIC code for TheraBiologics, Inc? The SIC codes for TheraBiologics, Inc are [873, 87]. Top …See details»
TheraBiologics Company Profile | Management and Employees List …
TheraBiologics Phase I lead program, TBX-01, is the firstin-human clinical trial of an FDA approved, genetically modified NSC line for ca ncer treatment. TheraBiologics is seeking $5 …See details»
TheraBiologics 2025 Company Profile: Valuation, Funding
TheraBiologics General Information Description. Developer of stem cell-mediated cancer therapies designed to help patients recover from cancer. The company's stem therapies …See details»
THERABIOLOGICS INC. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for THERABIOLOGICS INC. of Pasadena, CA. Get the latest business insights from Dun & …See details»
TheraBiologics Company Profile - Office Locations, Competitors
TheraBiologics is a biopharmaceutical company developing human neural stem cell (NSC)-mediated cancer therapies. Its TBX.NSC platform delivers a range of potent anti-cancer …See details»
Therabiologics - VentureRadar
Similar Companies: Celyad SA (formerly known as Cardio3 Belgium Publicly Traded Celyad Oncology is a clinical-stage biotechnology company focused on the discovery and …See details»
TheraBiologics - Crunchbase
TheraBiologics develops a proprietary human NSC platform for cancer treatment. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. Log In. Experience the new Crunchbase, powered by AI . Experience …See details»
TheraBiologics, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore TheraBiologics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news, Drug:Neural stem cell therapy (TheraBiologics), TBX-04.See details»
TheraBiologics - 2025 Company Profile & Competitors - Tracxn
Feb 27, 2025 TheraBiologics - Developer of cancer therapies using their proprietary neural stem-cell-based platform. This company is not active anymore. Founded by Karen Aboody in the …See details»
TheraBiologics - Funding, Financials, Valuation & Investors
Jul 30, 2012 How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jul 30, 2012: …See details»
TheraBiologics, Inc. - EquityNet
TheraBiologics Phase I lead program, TBX-01, is the first–in-human clinical trial of an FDA approved, genetically modified NSC line for cancer treatment. TheraBiologics is seeking $5 …See details»
Therabiologics | VentureRadar
The Company’s TBio-NSC platform enables the targeted delivery of potent therapeutics to tumors. TheraBiologics Phase I lead program, TBio-01, is the first–in-human clinical trial of an FDA …See details»
TBX-04 - Drug Targets, Indications, Patents - Synapse
TBX-04, Initially developed by TheraBiologics, Inc., Now, its global highest R&D status is Pending, Therapeutic Areas: Neoplasms,Skin and Musculoskeletal Diseases. ... Originator …See details»
Neural stem cell therapy (TheraBiologics) - Drug Targets, …
Neural stem cell therapy (TheraBiologics): a Cell replacements Drug, Initially developed by TheraBiologics, Inc., Now, its global highest R&D status is Pending, Mechanism: Cell …See details»
TheraBiologics - Contacts, Employees, Board Members, Advisors
TheraBiologics has 2 current employee profiles, including Director, Founder & Chief Scientific Officer Karen Aboody. TheraBiologics has 1 board member or advisor, Tom Smart . ContactsSee details»
Thera Biologics
Bienvenido a Thera Biologics S.A.S. Nuestra principal actividad es la de atender las necesidades de los productores y demás personas interesadas en el registro de plaguicidas de uso …See details»
Theratechnologies Receives FDA Approval for EGRIFTA WR™ …
New, improved formulation set to replace EGRIFTA SV ®. MONTREAL, March 25, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) …See details»
Neural stem cell therapy - TheraBiologics - AdisInsight - Springer
TheraBiologics is developing genetically-modified neural stem cells (NSCs) for the treatment of glioma. These NSCs are able to selectively migrate to invasive ... If your organization has a …See details»
TheraBiologics - Tech Stack, Apps, Patents & Trademarks
TheraBiologics uses 3 technology products and services including Wordpress, Google Compute Engine, and GoDaddy Premium DNS, according to G2 Stack. TheraBiologics is actively using …See details»
GenVec and TheraBiologics form Collaboration to Develop Neural …
Mar 23, 2015 About TheraBiologics. TheraBiologics is a clinical-stage biopharmaceutical company developing human neural stem cell (NSC)-mediated cancer therapies. …See details»